Analysis of TWILIGHT trial shines light on Effect of Therapies following percutaneous coronary intervention
News | SCAI
Ticogrelor Monotherapy Post PCI Associated with Similar Rates of Revascularization as Duel Antiplatelet Therapy

June 1, 2023 — New insights from the TWILIGHT trial showed that ticagrelor monotherapy after three months of ticagrelor ...

Home June 01, 2023
Home
ACC Care of the Athletic Heart highlights latest advances in the field of sports cardiology
News | ACC
American College of Cardiology to Host Sports Cardiology Conference

June 1, 2023 — The American College of Cardiology will host the annual Care of the Athletic Heart course on June 8-10 ...

Home June 01, 2023
Home
Here's a look at what viewers found most interesting during the month of May on DIcardiology.com
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Top 10: A Look at What Caught Your Eye in May

It's been a fruitful month for DIcardiology.com! Here's a look at what DAIC viewers found to be most interesting during ...

Home June 01, 2023
Home
Rechargeable multi-parameter wearable patch enables continuous and real time monitoring of remote patients
News | Wearables
Vivalink Releases 14-Day Live Stream Wearable ECG Patch for Ambulatory Cardiac Monitoring

May 31, 2023 — Vivalink, a leading provider of digital healthcare solutions, is announcing the newest version of its ...

Home May 31, 2023
Home
There are currently no FDA approved treatments for PH-HFpEF, a condition affecting more than 1,600,000 North Americans, with estimates indicating a prevalence of more than 2,000,000 patients by 2030
News | Pharmaceuticals
Tenax Therapeutics Achieves Major Milestone as USPTO Grants Notice of Allowance for U.S. Patent Application Covering Use of Oral Levosimendan (TNX-103) in PH-HFpEF

May 31, 2023 — Tenax Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, developing and ...

Home May 31, 2023
Home
Cytomegalovirus (CMV) is one of the most prevalent herpesviruses worldwide.
News | Coronavirus (COVID-19)
People Coinfected with SARS-CoV-2 and Cytomegalovirus are at Increased Risk of Developing Cardiovascular Disease

May 31, 2023 — Cytomegalovirus (CMV) is one of the most prevalent herpesviruses worldwide. Depending on the geographical ...

Home May 31, 2023
Home
A new report, “Digital Transformation in Healthcare Market,” from Future Market Insights, Inc., found that by the end of 2023, the fast-paced sector is expected to be worth $65.2 billion.
News | Cardiovascular Business
Healthcare Digital Transformation Market Report Forecasts Major Growth thru 2033

May 31, 2023 — A new report is shedding light on the fast pace of growth in the digital heath sector at present and over ...

Home May 31, 2023
Home
News | AHA
Impacts of Chronic Stress on Cardiovascular Disease Risk to be Focus of American Heart Association (AHA) $15 Million Research Project

May 31, 2023 — The American Heart Association (AHA) has announced that teams of research scientists from three ...

Home May 31, 2023
Home
The objective of this study was to assess the safety and efficacy of SELUTION SLR, MedAlliance’s novel sirolimus-eluting balloon, for endovascular therapy of de novo and non-stented restenotic lesions in the superficial femoral artery (SFA) and popliteal artery (PA).
News | Drug-Eluting Balloons
Excellent 12-Month Results from SELUTION SFA Trial Presented at JET

May 30, 2023 — Twelve-month results from the SELUTION SFA trial have been presented for the first time at the Japan ...

Home May 30, 2023
Home
MagicTouch PTA -Sirolimus Coated Balloon has recently received IDE approval from the US FDA for SFA indication
News | Drug-Eluting Balloons
Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

May 30, 2023 — The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for ...

Home May 30, 2023
Home
Thirona’s AI-Based LungQAVX Reveals New Potential for Treatment of Vascular Diseases
News | Artificial Intelligence
Artificial Intelligence Could Enable Life-Saving Early Diagnosis and Advance the Treatment of Pulmonary Hypertension

May 30, 2023 — Thirona, a global company specialized in advanced analysis of thoracic CT images with artificial ...

Home May 30, 2023
Home
Sponsored Content | Case Study | Enterprise Imaging
Re-Architecting a Hemo System Using Behavioral Science

Behavioral science is being applied in unique ways for enterprise imaging product design. Involving clinicians in the ...

Home May 30, 2023
Home
Through ACC Global Quality Solutions Program, Dnipro hospital CV teams are enhancing skills and raising quality of care for local heart attack patients
News | ACC
Ukraine Hospital Improving Emergency Cardiovascular Care During National Crisis

May 26, 2023 — The Clinical Hospital of Emergency Services, a municipal hospital serving the community of Dnipro, in ...

Home May 26, 2023
Home
MONITOR-HF is the third randomized, controlled trial globally to show a significant health benefit for indicated heart failure patients
News | Heart Failure
European Study Finds the Abbott Cardiomems Sensor Results in Improved Quality of Life and 44% Reduction in Heart Failure Hospitalizations

May 25, 2023 — New data presented from an investigator-sponsored European trial found managing indicated1 heart failure ...

Home May 26, 2023
Home
Emile Daoud, MD, helped develop a new surgical device at The Ohio State University Wexner Medical Center to prevent a common and serious complication during heart ablation procedures. The device gently moves the nearby esophagus away from the heart to prevent the ablation energy from causing damage.
News | Atrial Fibrillation
New Device Helps Prevent Complication During Common Heart Procedure

May 26, 2023 — Atrial fibrillation, or AFib , is the most common heart rhythm problem, affecting millions of Americans ...

Home May 26, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now